期刊文献+

绝经期后女性同型半胱氨酸、高敏C反应蛋白水平与冠状动脉病变及传统危险因素的关系 被引量:9

Association of High-sensitivity C Reactive Protein,Homocysteine with Coronary Lesions and Traditional Cardiovascular Risk Factors in Postmenopausal Women
原文传递
导出
摘要 目的:观察绝经期后女性冠心病患者高敏C反应蛋白(hs-CRP)和同型半胱氨酸(Hcy)水平,并分析hs-CRP,Hcy与冠状动脉病变和其他传统危险因素的关系。方法:入选绝经期后女性冠心病患者150例(CHD组),同期选取同年龄段男性冠心病患者150例(男性CHD组)及冠状动脉造影阴性的女性146例(非CHD组)作为对照组,比较3组患者一般资料及hs-CRP,Hcy水平。评价绝经期后女性冠心病患者冠状动脉病变与hs-CRP,Hcy的关系,并进行hs-CRP,Hcy与血脂、血压等传统危险因素相关性分析。结果:绝经期后女性冠心病患者同男性相比患高血压、糖尿病者明显增多;吸烟者较少,肾小球滤过率下降,hs-CRP和Hcy水平增高(P<0.05)。绝经期后女性冠心病患者中三支病变者hs-CRP和Hcy水平较单支病变者显著增高(P<0.05);重度病变患者hs-CRP和Hcy水平较轻度病变者增高明显(P<0.05)。hs-CRP和Hcy呈正相关(r=0.472,P<0.001);Hcy与体重指数(BMI),收缩压,舒张压呈正相关;hs-CRP与BMI,收缩压呈正相关,与肾小球滤过率(GFR)呈负相关。结论:绝经期后女性冠心病患者hs-CRP及Hcy水平增高,两者呈现正相关,且与血压,肥胖具有相关性。 Objective: To study the contribution of high-sensitivity C reactive protein (hs-CRP) and homocysteine (Hcy) on coronary lesions and investigate the association of that with traditional cardiovascular risk factors in postmenopausal women. Method: This study involved 150 consecutive postmenopausal women (CHD female group) with coronary heart disease (CHD), 150 consecutive men with CHD (male group) and 146 postmenopausal women with non-CHD (non-CHD female group).All patients underwent coronary angiography.The levels of hs-CRP and Hcy were detected in three groups.The association of hs-CRP, Hcy with coronary lesions and traditional cardiovascular risk factors was analyzed. Result: There were significant difference traditional cardiovascular risk factors including hypertension, type 2 diabetes in CHD female group than male group, the levels of hs-CRP and Hcy higher in CHD female group, but smoking and glomerular filtration rate(GFR) lower in CHD female group.In postmenopausal women, increased number of compromised arteries and total Gensini scores for the lesions were associated with increased levels of hs-CRP and Hcy.Correlation analysis showed a significant correlation among hs-CRP and Hcy(r=0.472, P〈0.001); Hcy and body mass index(BMI), systolic blood pressure(SBP), diastdic blood pressure(DBP); hs-CRP and BMI, SBP in postmenopausal women. Conclusion: The levels of hs-CRP and Hcy significant increased in postmenopausal women, and associated with each other.There was significant correlation among two newly emerged cardiovascular risk factors and obesity, hypertension.
出处 《中国实验方剂学杂志》 CAS 北大核心 2013年第6期301-304,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 沈阳科学技术计划项目(F11-262-9-18) 辽宁省科学技术计划项目(2010020241-418)
关键词 冠状动脉疾病 绝经 C反应蛋白 同型半胱氨酸 coronary heart disease menopause C-reactive protein homocysteine
  • 相关文献

参考文献10

  • 1Kim H S, Abbasi F, Lamendola C, et al. Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women [J]. Am J Clin Nutr, 2001, 74(5): 592.
  • 2Vaidya D, Kelemen M D, Bittner V, et al. Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease [ J ]. J Womens Health (Larchmt), 2007, 16(2):228.
  • 3胡威,郭志刚,陈君,周忠江.女性冠心病患者危险因素与冠状动脉病变程度的相关性分析[J].南方医科大学学报,2009,29(2):307-309. 被引量:16
  • 4Rossi G P, Maiolino G, Seccia T M, et al. Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women[ J]. J Hypertens, 2006, 24 (5): 851.
  • 5Os I, Os A, Sandset P M, et al. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal lwomen with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine [ J ]. Cardiology, 2002, 98 (1/2) : 6.
  • 6Verhoef P. Hyperhomocysteinemia and risk of vascular disease in women [ J ]. Semin Thromb Hemost, 2000, 26 : 325.
  • 7Hoogeveen E K, Kostense P J, Jakobs C, et al. Hyperhomocysteinemia increases risk of death, especially in type II diabetes. Five-year follow-up of the hoorn study[J]. Circulation, 2000, 101 : 1506.
  • 8Ridker P M, Morrow D A. C-reaction protein and cardiovascular risk rational for screening and primary prevention[ J]. Am J C ardiol, 2003, 21 (3): 315.
  • 9彭永平,吴宗贵,江时森,宫剑滨,王立军,何松清.高龄女性冠心病患者冠脉造影特点及经皮冠状动脉介入治疗的临床观察[J].江苏医药,2010,36(6):631-633. 被引量:2
  • 10杨进刚,杨跃进.女性冠心病特点及介入治疗进展[J].心血管病学进展,2011,32(2):141-143. 被引量:21

二级参考文献39

  • 1胡大一.ACC 2004热点报道[J].中国医药导刊,2004,6(3):214-218. 被引量:2
  • 2杨进刚,胡大一.女性冠状动脉粥样硬化性心脏病患者诊治现状的反思[J].新医学,2005,36(6):368-370. 被引量:5
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 4Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women [J]. Circulation, 2004, 109(5): 672-93.
  • 5中华人民共和国卫生部高血压联盟.高血压防治指南[M].2005年修订版.北京:人民卫生出版社.2006:4.
  • 6中国2型糖尿病防治指南制订委员会.中国2型糖尿病防治指南[M].2007年版.
  • 7Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (5): 606.
  • 8Mosca L, Carole L Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in Women: 2007 Update [J]. Circulation, 2007, 115: 1481-501.
  • 9Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis [J ]. JAMA, 2005, 294(14): 1799-809.
  • 10Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilimbin with increased risk of coronary artery disease [J]. Clin Chem, 1994, 40:18-23.

共引文献36

同被引文献91

  • 1胡庭俊,何彩美,钟晶.鸡血藤不同极性段提取物制备及体外抑菌作用初步研究[J].动物医学进展,2010,31(9):33-36. 被引量:21
  • 2汶麦霞,田华,张倩蓉,郑小璞,饶坤睿,袁红.绝经对女性冠心病患者临床特征及危险因素的影响[J].西安交通大学学报(医学版),2012,33(3):321-323. 被引量:18
  • 3王晓蓉.冠心病患者检测同型半胱氨酸以及超敏C反应蛋白的临床价值[J].环球中医药,2013,6(S1):90-91. 被引量:3
  • 4乐杰.妇产科学[M].7版.北京:人民卫生出版社,2010:366.
  • 5Jackson KC,Wohlers LM,Valencia AP,et al.Wheel running prevents the accumulation of monounsaturated fatty acids in the liver of ovariectomized mice by attenuating changes in SCD-1 content[J].Appl Physiol Nutr Metab,2011,36(6):798-810.
  • 6Sattar N,Preiss D,Murray HM,et al.Statins and risk of incident diabetes:a collaborative meta-analysis of randomised statin trials[J].Lancet,2010,375(9716):735-742.
  • 7Albert MA,Glynn RJ,Fonseca FA,et al.Race,ethnicity,and the efficacy of rosuvastatin in primary prevention:the Justification for the Lse of Statins in Prevention:an Intervention Trial Evaluating Rosuvastatin(J LPITER) trial[J].Am Heart J,2011,162 (1):106-114.
  • 8Mooradian AD.Dyslipidemia in type 2 diabetes mellitus[J].Nat Clin Pratc Endocrinol Metab,2009,5(3):150-159.
  • 9Gumprecht J,Gosho M,Budinski D,et al.Comparative long-term efficacy and tolerability of pitavastatin 4mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia[J].Deabetes Obes Metab,2011,13(11):1047-1058.
  • 10Magkos F,Fabbrini E,Mohammed BS,et al.Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype[J].J Clin Endocrinol Metab,2010,95(7):3377-3384.

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部